Newsroom

DALLAS--(BUSINESS WIRE)--Flowserve Corporation (NYSE: FLS), a leading provider of flow control products and services for the global infrastructure markets, announced that its Board of Directors has authorized a quarterly cash dividend of $0.21 per share on the Company’s outstanding shares of common stock. The dividend is payable on January 9, 2026, to shareholders of record as of the close of business on December 26, 2025. While Flowserve currently intends to pay regular quarterly cash dividend...

LONDON--(BUSINESS WIRE)--  10-December-2025 Issue: Newday Funding Master Issuer Plc SERIES 2024-2 Class E RegS XS2834468832 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 17-November-2025 Date To: 15-December-2025 Record Date: 12-December-2025 Value Date: 15-December-2025 Benchmark Rate: 3.97571% Margin: 3.9% Total Rate: 7.87571% Number of Days: 28 Day Count: Actual / 365L Interest Frequency: Monthly To...

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the U.S. Food and Drug Administration (FDA) has approved DAYBUE® STIX (trofinetide) for oral solution, a dye- and preservative-free powder formulation of trofinetide for the treatment of Rett syndrome in adult and pediatric patients two years of age and older. The new formulation is expected to deliver the same efficacy and safety profile of DAYBUE oral solution, while offering children and adults living...

SAN FRANCISCO--(BUSINESS WIRE)--Wells Fargo & Company (NYSE: WFC) (“Wells Fargo”) today announced that it will redeem all of its Floating Rate Junior Subordinated Deferrable Interest Debentures due January 15, 2027 (CUSIP No. 949746TG6*) (the “Debentures”) on January 15, 2026 (the “Optional Prepayment Date”). The optional prepayment price will be equal to 100% of the principal amount of the Debentures plus accrued and unpaid interest to, but excluding, the Optional Prepayment Date. Upon the...

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, and MEDSIR (Medica Scientia Innovation Research), a global leader in oncology research, today announced their collaboration on the MiRaDoR (NCT05708235) study, which is a multicenter, phase II clinical trial in hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer. Breast cancer is the most common cancer in women worldwide, with approximately 2.3 million new cases d...

NEW YORK--(BUSINESS WIRE)--Lightspeed IR is an institutional-grade investor relations platform built for professional allocators and Solana ecosystem stakeholders....

TINTON FALLS, N.J.--(BUSINESS WIRE)--Cherry Hill Mortgage Investment Corporation (NYSE: CHMI) today announced that its Board of Directors declared a dividend of $0.10 per share on the Company’s common stock for the fourth quarter of 2025. The dividend will be payable in cash on January 30, 2026 to holders of the common stock of record as of the close of business on December 31, 2025. Additionally, Cherry Hill announced that its Board of Directors has declared a dividend of $0.5125 per share on...

TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announced that it will change its corporate name from NanoVibronix, Inc. to ENvue Medical, Inc., effective December 12, 2025, to better reflect its new strategic direction and primary focus on its ENvue® feeding-tube placement system (“ENvue”). The Company’s ticker for its common stock, listed on the Nasdaq Capit...

CAMBRIDGE, Mass., AUSTIN, Texas & TEL AVIV, Israel--(BUSINESS WIRE)--NeuraLight, the leader in developing precision biomarkers for neurological disease, today announced that Prof. Thomas Südhof, a Nobel Prize-winning neuroscientist and one of the world’s leading Alzheimer’s disease researchers, has joined its Scientific Advisory Board. This follows the announcement that world-recognized neurologist Prof. Olivier Rascol, a co-creator of the current gold standard for measuring Parkinson’s disease...

CINCINNATI--(BUSINESS WIRE)--Fifth Third (Nasdaq: FITB) today announced that Thomas H. (Hal) Harvey will retire from its Board of Directors, and Priscilla Almodovar will join the Board, effective January 7, 2026. “Hal’s expertise and counsel have been invaluable to Fifth Third,” said Tim Spence, chairman, CEO and president of Fifth Third. “His deep knowledge of financial services and corporate governance, combined with his leadership in energy innovation and commitment to ethical business stand...